Case Control Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Aug 6, 2021; 9(22): 6244-6253
Published online Aug 6, 2021. doi: 10.12998/wjcc.v9.i22.6244
Table 1 Baseline patient characteristics
Variable
Intussusception group (n = 60)
Non-intussusception group (n = 100)
P value
Sex, n (%)0.383
Male33 (55.0)62 (62.0)
Female27 (45.0)38 (38.0)
Age at onset, n (%)< 0.001
< 6 yr27 (45.0)9 (9.0)
≥ 6 yr33 (55.0)91 (91.0)
Duration of disease (d), n (%)0.02
≤ 2858 (96.7)85 (85.0)
> 282 (3.3)15 (15.0)
First episode, n (%)0.017
Yes57 (95.0)80 (80.0)
No3 (5.0)20 (20.0)
GI tract malformation, n (%)0.117
Yes3 (5.0)1 (1.0)
No57 (95.0)99 (99.0)
Receiving glucocorticoid therapy within 72 h of GI symptom emergence, n (%)< 0.001
Yes20 (33.3)77 (77.0)
No40 (66.7)23 (23.0)
Vomiting, n (%)< 0.001
Yes39 (65.0)27 (27.0)
No21 (35.0)73 (73.0)
Hematemesis, n (%)0.204
Yes7 (11.7)6 (6.0)
No53 (88.3)94 (94.0)
Hematochezia, n (%)< 0.001
Yes33 (55.0)14 (14.0)
No27 (45.0)86 (86.0)
White blood cell count, n (%)0.014
< 10.0 × 109/L21 (35.0)55 (55.0)
≥ 10.0 × 109/L39 (65.0)45 (45.0)
Neutrophil count, n (%)0.085
< 10.0 × 109/L32 (53.3)67 (67.0)
≥ 10.0 × 109/L28 (46.3)33 (33.0)
Platelet count, n (%)0.168
< 300.0 × 109/L11 (18.3)28 (28.0)
≥ 300.0 × 109/L49 (81.7)72 (72.0)
C-reactive protein level, n (%)0.072
≤ 8 mg/L26 (43.3)58 (58.0)
> 8 mg/L34 (56.7)42 (42.0)
Erythrocyte sedimentation rate, n (%)0.388
≤ 15 mm/h50 (83.3)73 (73.0)
> 15 mm/h10 (16.7)27 (27.0)
D-dimer level, n (%)< 0.001
< 1 mg/L7 (11.7)70 (70.0)
≥ 1 mg/L53 (88.3)30 (30.0)